
Dentsply Sirona to present digital manufacturing strategies at NEXT3D 2026 conference.
Originally reported by 3Druck
Dentsply Sirona to present digital manufacturing strategies at NEXT3D 2026 conference. Dentsply Sirona, the Charlotte-based dental technology manufacturer, has confirmed its participation in the NEXT3D 2026 conference to discuss the integration of additive manufacturing within clinical dental workflows. The company will focus on the deployment of DLP and SLA technologies for the production of patient-specific dental appliances, including aligners, surgical guides, and restorative models. This session will detail how the firm leverages digital dentistry platforms to streamline the transition from intraoral scanning to high-throughput 3D printing, emphasizing material consistency and regulatory compliance in medical device production.
This participation highlights the ongoing convergence between industrial additive manufacturing and specialized medical applications. As a leader in the dental value chain, Dentsply Sirona competes with firms like Straumann and Align Technology, both of which are aggressively scaling their internal 3D printing capacities to reduce lead times. The dental sector remains one of the most mature markets for photopolymer-based additive manufacturing, with a compound annual growth rate projected to remain robust as chairside production becomes more accessible. By participating in a broader industrial forum like NEXT3D, Dentsply Sirona is positioning its proprietary digital ecosystem against broader industrial manufacturing standards, moving beyond niche dental-only trade shows.
For the dental sector, this move underscores the necessity of integrating high-speed, automated post-processing into the print workflow to achieve true industrial-scale throughput. Users should evaluate how Dentsply Sirona’s proprietary material validation processes compare to open-material platforms as they scale their own in-house production capabilities. Success for the company will depend on its ability to demonstrate that its closed-loop digital ecosystem offers superior clinical outcomes compared to third-party hardware and material alternatives.
Topics